stockrow
Saturday 7 November 2026
Export CLOV’s income statement to Excel — free account
Clover Health Investments, Corp.
CLOV Healthcare Healthcare Plans
Clover Health Investments, Corp.’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 40.3% from fiscal 2024.
- Revenue
- +52.9%
- EPS
- +350.0%
- Free cash flow
- +508.9%
Quarter to September 2026, against a year earlier
4.82
0.34
+7.59%
Follow CLOV
Alert me
Clover Health Investments, Corp. (CLOV) Total debt
Clover Health Investments, Corp.'s total debt at the end of fiscal 2023 was $1.4M, down 13.0% from $1.6M in fiscal 2022. Clover Health Investments, Corp. ranks 12th of 12 Healthcare Plans companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2023 | $1.4M | (12.96%) |
| FY2022 | $1.6M | (92.15%) |
| FY2021 | $19.9M | (84.33%) |
| FY2020 | $127.2M | — |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Dec 2023 | $1.4M | (54.57%) |
| Sep 2023 | $3.0M | (25.00%) |
| Jun 2023 | $4.0M | 0.00% |
| Mar 2023 | $4.0M | 155.43% |
| 10 more quarters | Free account |
Total debt against peers
| Company | Total debt |
|---|---|
| CI Cigna Group compare | $31.1B |
| ELV Elevance Health, Inc. compare | $30.8B |
| CNC Centene Corporation compare | $15.5B |
| HUM Humana Inc. compare | $12.5B |
| MOH Molina Healthcare, Inc compare | $4.0B |
| OSCR Oscar Health, Inc. compare | $432.4M |
| ALHC Alignment Healthcare, Inc. compare | $324.5M |
| PGNY Progyny, Inc. compare | $19.5M |
| CLOV Clover Health Investments, Corp. | $1.4M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on CLOV
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement